Publications by authors named "Lars-P Bechmann"

Claim this Profile
L
Long-term exposure to air pollution and prevalent nonalcoholic fatty liver disease.
Clara Matthiessen, Lina Glaubitz, Sarah Lucht, Julia Kälsch, Tom Luedde, Lars P Bechmann

Environ Epidemiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial DNA methylation in metabolic associated fatty liver disease.
Archibold Mposhi, Fabian Cortés-Mancera, Janette Heegsma, Vincent E de Meijer, Bart van de Sluis, Lars P Bechmann

Front Nutr· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of the Liver Maximum Function Capacity Test, Fibrinogen, and Transient Elastography in Patients with Acute Liver Injury.
Henriette Kreimeyer, Matthias Buechter, Jan Best, Robert K Gieseler, Antonios Katsounas, Lars P Bechmann

Dig Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis.
Catherine Leyh, Niklas Heucke, Clemens Schotten, Matthias Büchter, Lars P Bechmann

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics.
Svenja Sydor, Christian Dandyk, Johannes Schwerdt, Paul Manka, Dirk Benndorf, Lars P Bechmann

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease.
Peter Lemmer, Paul Manka, Jan Best, Alisan Kahraman, Julia Kälsch, Lars P Bechmann

J Clin Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver.
Paul Manka, Svenja Sydor, Julia M Schänzer-Ocklenburg, Malte Brandenburg, Jan Best, Lars P Bechmann

Metabolites· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics.
Jan Best, Lars P Bechmann

EBioMedicine· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-TNFα treatment in Crohn's disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status.
Paul Manka, Svenja Sydor, Nishikant Wase, Jan Best, Malte Brandenburg, Lars P Bechmann

Liver Int· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD).
Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, Beatriz Gómez-Santos, Patricia Aspichueta, Lars P Bechmann

Biomedicines· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients.
Clemens Schotten, Bastian Ostertag, Jan-Peter Sowa, Paul Manka, Lars P Bechmann

Pharmaceuticals (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model for end-stage liver disease-sodium in acute-on-chronic liver failure.
Paul Manka, Ali Canbay, Lars P Bechmann

J Hepatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Induction of Glycolysis and Oxidative Phosphorylation during Activation of Hepatic Stellate Cells Reveals Novel Mitochondrial Targets to Treat Liver Fibrosis.
Natalia Smith-Cortinez, Karen van Eunen, Janette Heegsma, Sandra Alejandra Serna-Salas, Svenja Sydor, Lars P Bechmann

Cells· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocyte KLF6 expression affects FXR signalling and the clinical course of primary sclerosing cholangitis.
Svenja Sydor, Paul Manka, Lea van Buren, Sarah Theurer, Suzan Schwertheim, Lars P Bechmann

Liver Int· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.
Jan Best, Lars P Bechmann, Jan-Peter Sowa, Svenja Sydor, Alexander Dechêne

Clin Gastroenterol Hepatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC.
Svenja Sydor, Jan Best, Insa Messerschmidt, Paul Manka, Ramiro Vilchez-Vargas, Lars P Bechmann

Clin Transl Gastroenterol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization.
Clemens Schotten, Lars P Bechmann, Paul Manka, Jens Theysohn, Alexander Dechêne

Liver Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injury.
Miguel E Zoubek, Marius M Woitok, Svenja Sydor, Leonard J Nelson, Lars P Bechmann

J Pathol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High ferritin levels are not only but mostly because of liver specific injury.
Olympia Anastasiou, Lars Peter Bechmann, Ali Canbay

Liver Int· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic stellate cell autophagy in acute liver injury: A novel role for nitric oxide?
Svenja Sydor, Lars P Bechmann

Liver Int· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury.
Svenja Sydor, Paul Manka, Jan Best, Sami Jafoui, Jan-Peter Sowa, Lars P Bechmann

Sci Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis.
Svenja Sydor, Jan-Peter Sowa, Dominik A Megger, Martin Schlattjan, Sami Jafoui, Lars P Bechmann

Mol Metab· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiology, outcome and prognostic factors of childhood acute liver failure in a German Single Center.
Simone Kathemann, Lars P Bechmann, Jan-Peter Sowa, Paul Manka, Alexander Dechêne

Ann Hepatol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
Francisco Javier Cubero, Miguel Eugenio Zoubek, Wei Hu, Jin Peng, Gang Zhao, Lars P Bechmann

Gastroenterology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort.
Julia Kälsch, Lars P Bechmann, Dominik Heider, Jan Best, Paul Manka

Sci Rep· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis